Solvay Picks Up Tricor Franchise Through Acquisition Of Fournier Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
Fournier's co-marketing agreement with Abbott for the lipid-lowering product will remain unchanged following Solvay's €1.3 bil. acquisition of the French company. Solvay will build a new cardio-metabolic division from Fournier, to be headquartered in Paris.